Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MYCN amplification remains prognostically strong 20 years after its "clinical debut".

Literature DB >> 15571946

MYCN amplification remains prognostically strong 20 years after its "clinical debut".

Susan L Cohn, Deborah A Tweddle.

Abstract

Entities: Gene

Mesh：

Year: 2004 PMID： 15571946 DOI： 10.1016/j.ejca.2004.07.025

Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Authors: Kevin Campbell; Derek Shyr; Rochelle Bagatell; Matthias Fischer; Akira Nakagawara; Adela Canete Nieto; Garrett M Brodeur; Katherine K Matthay; Wendy B London; Steven G DuBois
Journal: Pediatr Blood Cancer Date: 2019-05-21 Impact factor: 3.167

2. Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma.

Authors: Hanlee Ji; Jochen Kumm; Michael Zhang; Kyle Farnam; Keyan Salari; Malek Faham; James M Ford; Ronald W Davis
Journal: Cancer Res Date: 2006-08-15 Impact factor: 12.701

3. p53 is a direct transcriptional target of MYCN in neuroblastoma.

Authors: Lindi Chen; Nunzio Iraci; Samuele Gherardi; Laura D Gamble; Katrina M Wood; Giovanni Perini; John Lunec; Deborah A Tweddle
Journal: Cancer Res Date: 2010-02-09 Impact factor: 12.701

4. The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.

Authors: Dirk Geerts; Jan Koster; David Albert; Dana-Lynn T Koomoa; David J Feith; Anthony E Pegg; Richard Volckmann; Huib Caron; Rogier Versteeg; André S Bachmann
Journal: Int J Cancer Date: 2010-05-01 Impact factor: 7.396

5. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.

Authors: Eva Villamón; Marta Piqueras; Carlos Mackintosh; Javier Alonso; Enrique de Alava; Samuel Navarro; Rosa Noguera
Journal: Virchows Arch Date: 2008-06-24 Impact factor: 4.064

6. Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.

Authors: Zaowen Chen; Yunfu Lin; Eveline Barbieri; Sue Burlingame; John Hicks; Andrew Ludwig; Jason M Shohet
Journal: Neoplasia Date: 2009-08 Impact factor: 5.715

7. N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53.

Authors: Rajiv Janardhanan; Naren L Banik; Swapan K Ray
Journal: Biochem Pharmacol Date: 2009-06-18 Impact factor: 5.858